这篇综述深入探讨了二聚体糖蛋白PSGL-1（P-选择素糖蛋白配体）在白细胞招募和炎症反应中的双重作用。文章系统梳理了PSGL-1 ...

PSGL-1作为全球创新的免疫治疗新靶点，能够引起巨噬细胞重编程并激发协同抗肿瘤反应。三生制药旗下子公司三生国健药业(上海)股份有限公司将 ...

P-selectin glycoprotein ligand 1 (PSGL-1) is central to the trafficking of immune effector cells to areas of inflammation through direct interactions with P-selectin, E-selectin and L-selectin.

The protein, P-selectin glycoprotein ligand 1 (PSGL-1), which exists in human cells, can inhibit the process by which HIV replicates, according to research published in the science journal Nature ...

Incidence and risk factors for pneumonitis associated with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer: A single center experience. This is an ASCO Meeting Abstract from ...

("Verseau") today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first licensed program under their partnership agreement focused on the development and ...

New research has identified a new regulator of immune responses. The study sheds new light on why T cells fail to clear chronic infections and eliminate tumors. Research led by scientists at the ...